Ferner R E, Kamali F, Rawlins M D
Wolfson Unit of Clinical Pharmacology, University of Newcastle upon Tyne.
Br J Clin Pharmacol. 1991 Jan;31(1):114-6. doi: 10.1111/j.1365-2125.1991.tb03869.x.
The effects of pretreatment with enalapril, and sulindac, on the weal response to intradermal injections of substance P and neurokinin A were assessed in a randomised, double-blind, placebo-controlled study. Weal responses to both substance P and neurokinin A depended significantly on dose. Neither enalapril nor sulindac, nor the combination of these agents influenced the responses to either tachykinin. These results do not suggest any role for substance P or neurokinin A in the clinical effects of angiotensin converting enzyme inhibitors.
在一项随机、双盲、安慰剂对照研究中,评估了依那普利和舒林酸预处理对皮内注射P物质和神经激肽A所致风团反应的影响。对P物质和神经激肽A的风团反应均显著依赖于剂量。依那普利、舒林酸或二者联合使用均不影响对任何一种速激肽的反应。这些结果并不提示P物质或神经激肽A在血管紧张素转换酶抑制剂的临床效应中起任何作用。